Results 151 to 160 of about 13,112,507 (171)

Burden of Glucocorticoid Use and Risk of Toxicities Among Patients with Immunoglobulin-G4-Related Disease: A Retrospective US-Based Claims Study. [PDF]

Rheumatol Ther
Wallace ZS, Park JY, Serra E, Gagnon-Sanschagrin P, Guérin A, Patterson K, Patel H, Singh VK.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Immunoglobulin A Targets a Unique Subset of the Microbiota in Inflammatory Bowel Disease

Cell Host and Microbe, 2021
Bruce E. Sands, Noah W Palm, Neal Leleiko   +2 more
exaly  

High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019.

Open Forum Infectious Diseases, 2020
Xiaosheng Liu, Tao Bai, Taisheng Li
exaly  

Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki Disease

Circulation, 2006
Tohru Kobayashi, Tomio Kobayashi, Kazushi Tamura   +2 more
exaly  

Evaluation of Kawasaki Disease Risk-Scoring Systems for Intravenous Immunoglobulin Resistance

Journal of Pediatrics, 2011
Andrew Atz, L Luann Minich
exaly  

Resistance to Intravenous Immunoglobulin in Children with Kawasaki Disease

Journal of Pediatrics, 2008
Jane C. Burns, Brookie Best, Adriana Tremoulet   +2 more
exaly  

Infliximab for Intravenous Immunoglobulin Resistance in Kawasaki Disease: A Retrospective Study

Journal of Pediatrics, 2011
Jane C. Burns, Adriana Tremoulet, Robert P. Sundel   +2 more
exaly  

Role of intravenous immunoglobulin in the treatment of Kawasaki disease

International Journal of Rheumatic Diseases, 2018
Mindy S Lo
exaly  

Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance

Human Immunology, 2010
Jane C. Burns, Chisato Shimizu, John Kanegaye   +2 more
exaly  

Infliximab Treatment of Intravenous Immunoglobulin–Resistant Kawasaki Disease

Journal of Pediatrics, 2008
Asuncion Mejias, Hasan Jafri, Edmund V Capparelli   +2 more
exaly